Derby medical devices firm SurePulse is spearheading a new UK-Texas life sciences trade deal that the government says will provide direct access to the largest medical complex in the world.
The Department for International Trade (DIT) have announced that it has agreed a landmark ‘BioBridge’ collaboration with the Texas Medical Center (TMC) the world’s largest medical complex – with Derby-based SurePulse Medical one of just two companies which is in the initial stages of engagement with TMC ahead of major presentations to hundreds of investors, industry leaders and hospitals at ‘Demonstration Days’ in Texas.
SurePulse Medical is a joint venture between the University of Nottingham and Tioga and makes vital sign monitoring equipment. The company is based on Mansfield Road in Derby.
The TMC, home to 61 world leading innovators, including the US’ leading cancer hospital, will now offer Surepulse a unique package, says the DIT, which will help boost exports and drive forward scientific innovation.
The US spent $3.3tn on healthcare in 2016, which was 18% of GDP. National health expenditure is projected to grow to $5.7tn in 2026, which would be nearly 20% of GDP.
As part of the deal, British life sciences businesses will now be able to locate themselves at the TMC in Houston, where they will have access to a network of advisors, investors and medical experts from both the Center and DIT.
The partnership will allow for a “significant research collaboration” on a wide range of medical issues, including the development and advancement of Genomics and Cancer treatments.
News & Analysis